
Sign up to save your podcasts
Or


What if the future of chemistry didn’t rely on cells or even nature itself to create the world’s most valuable molecules?
In this episode of Lightning RX, host Colette Nataf sits down with Michael Heltzen, CEO of eXoZymes Inc. (Nasdaq: EXOZ), to explore how his company is redefining biomanufacturing through exozymes, a revolutionary technology that uses AI-driven evolution to create natural products at an industrial scale, without harvesting from nature.
Michael explains how eXoZymes’ cell-free biomanufacturing platform allows them to “brute-force evolution,” running what would take nature a billion years in just a week. By combining artificial intelligence with enzymatic chemistry, the company can produce rare and valuable natural compounds—like the metabolism-boosting molecule NCT and the fragrance powerhouse Santaline that were previously inaccessible due to scarcity or cost.
From AI-guided protein optimization to sustainable alternatives to petrochemicals, Michael’s work represents a new frontier in synthetic biochemistry, one that merges environmental responsibility, efficiency, and scientific creativity.
What You’ll Learn:
💡 Golden Nugget:
“AI and enzymes are teaching us that evolution isn’t just a process, it’s a platform we can engineer for sustainable abundance.”
Connect with Michael Heltzen
Connect with the Show:
Subscribe on Spotify, Apple Podcasts, or your favorite platform.
If you enjoyed this episode, share it with someone passionate about healthcare marketing, startup growth, or innovative product launches, and don’t forget to leave us a review. New episodes drop weekly!
By Colette NatafWhat if the future of chemistry didn’t rely on cells or even nature itself to create the world’s most valuable molecules?
In this episode of Lightning RX, host Colette Nataf sits down with Michael Heltzen, CEO of eXoZymes Inc. (Nasdaq: EXOZ), to explore how his company is redefining biomanufacturing through exozymes, a revolutionary technology that uses AI-driven evolution to create natural products at an industrial scale, without harvesting from nature.
Michael explains how eXoZymes’ cell-free biomanufacturing platform allows them to “brute-force evolution,” running what would take nature a billion years in just a week. By combining artificial intelligence with enzymatic chemistry, the company can produce rare and valuable natural compounds—like the metabolism-boosting molecule NCT and the fragrance powerhouse Santaline that were previously inaccessible due to scarcity or cost.
From AI-guided protein optimization to sustainable alternatives to petrochemicals, Michael’s work represents a new frontier in synthetic biochemistry, one that merges environmental responsibility, efficiency, and scientific creativity.
What You’ll Learn:
💡 Golden Nugget:
“AI and enzymes are teaching us that evolution isn’t just a process, it’s a platform we can engineer for sustainable abundance.”
Connect with Michael Heltzen
Connect with the Show:
Subscribe on Spotify, Apple Podcasts, or your favorite platform.
If you enjoyed this episode, share it with someone passionate about healthcare marketing, startup growth, or innovative product launches, and don’t forget to leave us a review. New episodes drop weekly!